Elizabeth Garrett Ingram, Director at AVENUE THERAPEUTICS, INC. (ATXI), bought 16,000 shares at $6.27 ($100K) on 2019-09-12, disclosed to the SEC on 2019-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.